Hikma Pharmaceuticals agrees USD50 million settlement for Xyrem claims
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday announced it has reached a settlement deal for up to USD50 million in cash for litigation brought against the firm in relation to its narcolepsy treatment Xyrem. Read More